Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3678502014 | Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3678504010 | Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 108430301000001115 | Efavirenz 600 mg and emtricitabine 200 mg and tenofovir 300 mg oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Is a | Product containing efavirenz and emtricitabine and tenofovir | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has active ingredient | Emtricitabine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has active ingredient | Tenofovir disoproxil fumarate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has active ingredient | Efavirenz | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Is a | Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has active ingredient | Tenofovir disoproxil fumarate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Tenofovir disoproxil fumarate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has active ingredient | Efavirenz | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Efavirenz | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 600 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has active ingredient | Emtricitabine | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Emtricitabine | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Tenofovir disoproxil fumarate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Efavirenz | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Emtricitabine | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Is a | Product containing only efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR